Treatment of Bacterial Infections with β-Lactams: Cooperation with Innate Immunity - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue (Article De Synthèse) Infection and Immunity Année : 2023

Treatment of Bacterial Infections with β-Lactams: Cooperation with Innate Immunity

Résumé

β-Lactams are the most widely prescribed antibiotics used for the control and treatment of bacterial infections. The direct effect of β-lactams on bacteria is well studied worldwide. In the context of infections and as a consequence of their direct activity against the pathogen, β-lactams also regulate antibacterial immune responses. This knowledge has led to the theorem that the effectiveness of β-lactam treatment results from the synergy between the drug and the immune response. Key players in this immune response, with an essential role in the clearance of live and dead bacteria, are the myeloid cells. In this review, we summarize the data that shed light on how β-lactams interact with myeloid cells during bacterial infection treatment.
Fichier principal
Vignette du fichier
Minireview Mondemé et al 2023.pdf (713.33 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04238526 , version 1 (13-10-2023)

Licence

Paternité

Identifiants

Citer

Mélanie Mondemé, Christophe Carnoy, Jean-Claude Sirard, Christelle Faveeuw. Treatment of Bacterial Infections with β-Lactams: Cooperation with Innate Immunity. Infection and Immunity, 2023, 91 (2), pp.e00503-22. ⟨10.1128/iai.00503-22⟩. ⟨hal-04238526⟩
19 Consultations
13 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More